Records containing: Open-Angle Glaucoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-12-05Comparison of Safety and Efficacy of Al-37807 Ophthalmic Suspension vs. Timolol Gel Forming Solution and Vehicle, All Dosed Concomitantly With Xalatan in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2012-11-30A Dose-Volume Study of the Safety and IOP-Lowering Efficacy of Anecortave Acetate in Patients With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2012-10-04A Study of the Glaukos Trabecular Micro-Bypass Stent in Combination With Cataract Surgery in Open Angle Glaucoma Subjects.
-
CLINICAL_TRIALS study record update · 2012-05-30ClinicalTrials.gov study NCT00705770
-
CLINICAL_TRIALS study record update · 2012-03-16A Comparative Analysis of the Effects of Cosopt® Versus Xalacom® on Ocular Hemodynamics and Intraocular Pressure in Patients With Primary Open-angle Glaucoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-02-14ClinicalTrials.gov study NCT00293800
-
CLINICAL_TRIALS study record update · 2012-01-18Goniocurettage as First Choice of Surgical Treatment in Chronic Open-Angle Glaucoma: Outcomes and Complications
-
CLINICAL_TRIALS study record update · 2012-01-06ClinicalTrials.gov study NCT00716742
-
CLINICAL_TRIALS study record update · 2011-11-03A Randomized, Double-masked, Placebo- and Active-controlled, Multi-Center, Dose Escalation Trial of DE-104 Ophthalmic Solution in Japanese and Non-Japanese Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2011-11-03A Randomized, Double-masked, Placebo- and Active- Controlled, Parallel-group, Multi-center, Dose-response Trial of DE-104 Ophthalmic Solution in Subjects With Primary Open-angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2010-11-04ClinicalTrials.gov study NCT00168350
-
CLINICAL_TRIALS study record update · 2010-11-04ClinicalTrials.gov study NCT00141882
-
CLINICAL_TRIALS study record update · 2010-02-10ClinicalTrials.gov study NCT00527592
-
CLINICAL_TRIALS study record update · 2009-10-01Collection of Blood Specimens From Patients in AL-3789 Studies for Elevated Intraocular Pressure (IOP)
-
CLINICAL_TRIALS study record update · 2009-09-15Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation in Patients With Open-angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2009-03-16A Randomized, Double-Masked, Parallel-Group, Dose-Response Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2009-03-16A Randomized, Double-Masked, Parallel-Group Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
-
CLINICAL_TRIALS study record update · 2009-01-14ClinicalTrials.gov study NCT00822081
-
CLINICAL_TRIALS study record update · 2009-01-14ClinicalTrials.gov study NCT00822055
-
CLINICAL_TRIALS study record update · 2009-01-12Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops
-
CLINICAL_TRIALS study record update · 2008-12-05Dry Eye and Irritation Comparison of Latanoprost 0.005% With the Preservative Benzalkonium Chloride (BAC) Vs Travoprost 0.004% Without BAC
-
CLINICAL_TRIALS study record update · 2008-12-04Randomized, Investigator Masked Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG)
-
CLINICAL_TRIALS study record update · 2008-11-19ClinicalTrials.gov study NCT00273455
-
CLINICAL_TRIALS study record update · 2008-11-19ClinicalTrials.gov study NCT00273481
-
CLINICAL_TRIALS study record update · 2008-11-19ClinicalTrials.gov study NCT00273442